While GLP-1 receptor agonists like semaglutide offer substantial weight loss and metabolic benefits, new guidance emphasizes that long-term success requires structured follow-up, attention to muscle mass and nutrition, and a relapse prevention plan.
Study Details
GLP-1 receptor agonists including semaglutide and tirzepatide have gained prominence in obesi…



